What is the Comprehensive Digestive Stool Analysis™ (CDSA 2.0)?
The Comprehensive Digestive Stool Analysis 2.0™ (CDSA 2.0) provides unique insight into overall and gastrointestinal health by assessing a combination of novel stool biomarkers. The CDSA 2.0 provides an informative and flexible screening of gastrointestinal function providing information on:
- Digestion/Absorption:
- Pancreatic Elastase 1
- Putrefactive Short–Chain Fatty Acids
- Additional biomarkers available
- Inflammation/Immunology:
- Eosinophil Protein X (EPX)
- Calprotectin
- Gut Metabolic Markers
- Beneficial Short–Chain Fatty Acids (SCFA) with n–Butyrate
- pH
- Beta–Glucuronidase
- Secondary Bile Acids
- Lithocholic acid (LCA)
- Deoxycholic acid (DCA)
- LCA/DCA Ratio
- Gut Microbiology Markers
- Beneficial Bacteria
- Additional Bacteria
- Mycology
- Parasitology Microscopic
- Parasitology EIA
- Cryptosporidium
- Giardia lamblia
- Entamoeba histolyti
When Should the CDSA 2.0 be considered?
CDSA 2.0 can reveal important clinical information about many common symptoms such as gas, bloating, abdominal pain, diarrhea, and constipation. This stool analysis also provides assessment for a differential diagnosis between inflammatory bowel disease and irritable bowel syndrome, plus a reliable assessment of exocrine pancreatic function. In addition, patients with risk factors for parasite acquisition can be evaluated with the CDSA 2.0.
What advantage does the CDSA 2.0 offer compared to other diagnostics?
Traditional GI testing has required advanced imaging and inconvenient testing procedures that can be costly. The CDSA 2.0 stool analysis offers a user-friendly way to provide clinicians with valuable insight into GI imbalances
What can clinicians and patients expect from the CDSA 2.0 offer compared to other diagnostics?
Evidence suggests that both local and systemic health issues may begin as imbalances in Gastrointestinal function. The CDSA 2.0 stool test provides immediate, actionable clinical information for patients presenting with GI complaints. It aids clinicians in the identification of root cause(s) of digestive discomfort and supports identification of targeted treatments.
